Quarterly report · Q3
2533.TEDINET S100PEZ2
Period2022-01-01 → 2022-09-30
Filed2022-11-04
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥58.0bn | 2022-01-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥78.6bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥56.8bn | 2021-01-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | −¥869m | 2022-01-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥952m | 2021-01-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | −¥799m | 2022-01-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥993m | 2021-01-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥909m | 2022-01-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥278m | 2021-01-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.4bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥299m | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥206m | 2021-01-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥1.5bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥188m | 2021-01-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥52.5bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥52.3bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥49.5bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥32.2bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥30.2bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.3bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥22.0bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥22.1bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥631m | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥990m | at 2021-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-22.73 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-10.21 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.03 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.48 | 2021-01-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.91 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 35.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.3% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.5% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-09-30 | ¥57m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-09-30 | ¥57m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-09-30 | ¥11m |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-09-30 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-09-30 | −¥2m |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥381m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥51.9bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥51.9bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥2m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥1.1bn |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥286m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥286m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥151m |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥273m |
| —segment total | revenue | 2022-01-01 → 2022-09-30 | ¥57.9bn |
| —segment total | revenue external | 2022-01-01 → 2022-09-30 | ¥57.9bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥2m |
| —segment total | segment profit | 2022-01-01 → 2022-09-30 | −¥880m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-01-01 → 2021-09-30 | ¥50m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-01-01 → 2021-09-30 | ¥50m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-09-30 | ¥9m |
| Reconciling Itemsreconciling | revenue | 2021-01-01 → 2021-09-30 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-01 → 2021-09-30 | −¥1m |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥505m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥51.0bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥51.0bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥1m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥318m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥265m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥265m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥139m |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥2.8bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥2.8bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | segment profit | 2021-01-01 → 2021-09-30 | −¥20m |
| —segment total | revenue | 2021-01-01 → 2021-09-30 | ¥56.7bn |
| —segment total | revenue external | 2021-01-01 → 2021-09-30 | ¥56.7bn |
| —segment total | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥1m |
| —segment total | segment profit | 2021-01-01 → 2021-09-30 | ¥943m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 421
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)EY新日本有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)石 田 大 輔 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)小 宮 正 俊 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 56765000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 57992000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 78618000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 993000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | -799000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1267000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 206000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | -1351000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 299000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 449000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | -1298000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 399000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 22094000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 20309000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 22045000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 49520000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 52534000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 52280000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 3.48 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | -22.73 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 5.03 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.405 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.351 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.383 | |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | -5.91 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | -10.21 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 65586196 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 65586196 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 65586196 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 65586196 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 6153600 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 59360500 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 593605 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 72096 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 65586196 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 598518 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 5662300 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | 491300 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |